IVF 서비스 시장은 2019년 134억 9629만 달러였으며 2027년에는 316억 1376만 달러에 이를 것으로 예상됩니다. 2020년부터 2027년까지 CAGR 11.6%로 성장할 것으로 예상됩니다.
IVF 또는 체외 수정은 여성의 난소에서 난자와 남성의 정자 샘플을 검색하고 실험실 유리 접시에서 외부적으로 수동으로 확산되었습니다. 수정 후 이 수정란은 며칠 동안 배아 배양을 거쳐 같은 여성 또는 다른 여성의 자궁으로 옮겨져 성공적인 임신이 이루어집니다.
IVF 서비스 시장은 주기 유형, 최종 사용자를 기준으로 세분화됩니다. , 그리고 지리. 지리를 기반으로 시장은 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미로 분류됩니다. 이 보고서는 시장 동향, 기술 발전, 시장 역학 및 전 세계 주요 시장 참가자의 경쟁 구도 분석과 같은 다양한 매개 변수를 강조하는 IVF 서비스 시장에 대한 통찰력과 심층 분석을 제공합니다. 또한 모든 지역에 대한 COVID-19 영향 분석도 포함됩니다. COVID-19 대유행 기간 동안 IVF 서비스가 감소하여 일부 의료 서비스에 대한 엄격한 폐쇄로 인해 예측 기간 동안 시장이 더 느린 속도로 성장할 것으로 예상됩니다.
수익이 좋은 지역 IVF 서비스 시장
시장 통찰력
불임 발생률 증가
전 세계적으로 출산율은 늦은 결혼 증가 추세, 연령 관련 불임 증가. 세계 출산율은 2030년까지 여성 1인당 2.4명, 2050년까지 여성 1인당 2.2명으로 떨어질 것으로 예상됩니다. 미국에서 15-44세 여성의 약 12%는 결혼 상태에 관계없이 임신에 어려움을 겪거나 임신 기간을 유지하는 데 어려움을 겪었습니다. . 또한 미국의 15세에서 44세 사이의 기혼 여성의 약 6.0%는 1년 동안 시도한 후에도 임신이 불가능합니다(불임). 국립보건통계센터(National Center for Health Statistics)에 따르면 2018년 미국의 출생률은 인구 1,000명당 11.968명으로 2017년보다 0.95% 감소한 것으로 추산되었습니다. 또한 클라미디아 질환은 미국에서 연간 약 400만~500만 건의 감염을 유발합니다. 제때 치료하지 않으면 남성과 여성 모두에게 불임을 유발할 수 있습니다.
또한 2019년 세계 출산 보고서에 따르면 2015~2020년 동안 최소 90,000명의 인구. 모든 주요 지역에서 빠른 출산율 감소가 관찰되었습니다. 1990-1995년과 2015-2020년 사이에 청소년 출산율이 50% 이상 감소한 77개 국가 및 지역 중 유럽 28개, 아시아 28개, 아프리카(알제리, 보츠와나 등) 8개, 카리브해 7개 (바하마, 푸에르토리코, 그레나다, 아루바, 마르티니크, 세인트루시아, 미국령 버진 아일랜드), 오세아니아(괌, 키리바시, 미크로네시아, 뉴칼레도니아), 캐나다와 미국에 4개 있습니다. 따라서 출산율 감소는 남성과 여성의 가임 기간을 결정하는 체외 수정(IVF) 서비스에 대한 수요를 크게 증가시킵니다.
주기 유형 기반 통찰력
주기 유형에 따라 IVF 서비스 시장은 신선한 IVF 주기, 해동된 IVF 주기 및 기증자 난자 IVF 주기로 분류됩니다. 새로운 IVF 주기 부문은 2019년에 시장에서 가장 큰 점유율을 차지했으며 동일한 부문이 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.
주기 유형별 글로벌 IVF 서비스 시장 - 2019 & 2027
최종 사용자 기반 통찰력
최종 사용자를 기준으로 IVF 서비스 시장은 병원, 불임 클리닉, 수술 센터 및 임상 연구 기관으로 분류됩니다. 불임 진료소 부문은 2019년 시장에서 가장 큰 점유율을 차지했습니다. 동일한 세그먼트가 2020-2027년 동안 시장에서 CAGR을 등록할 것으로 예상됩니다.
전략적 통찰력
파트너십, 인수합병과 같은 무기 전략은 일반적으로 기업이 충족하기 위해 채택합니다. 고객 수요를 변화시키고 전 세계적으로 개선된 서비스를 유지합니다. IVF 서비스 시장에서 활동하는 시장 참여자들은 제품 출시 및 확장과 같은 유기적 전략을 채택하여 전 세계적으로 입지와 제품 포트폴리오를 확장하고 증가하는 수요를 충족합니다.
주기 유형별
< ul>
최종 사용자별
- 불임 클리닉
- 병원
- 외과 센터 및 임상 연구 기관
지역별
- 북부 아메리카
- 미국
- 캐나다
- 멕시코
- 유럽
- 프랑스
- 독일
- 이탈리아
- 영국
- 스페인
- 기타 유럽
- 아시아 태평양(APAC)
- 중국
- 인도
- 대한민국
- 일본
- 호주< /li>
- 기타 APAC
- 중동 및 아프리카(MEA)
- 남아프리카
- 사우디아라비아
- UAE
- 나머지 MEA
li>
- 중남미(SCAM)
- 브라질
< li>아르헨티나 - 나머지 SCAM
회사 프로필
- Max Healthcare
- Bloom IVF
- CCRM Fertility.
- OXFORD FERTILITY
- Create Health(Create Fertility)
- Medicover
- BIOART Fertility Clinic
- Prelude Fertility, Inc.
- Gift ov life
< li>Aevitas Fertility Clinic
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
IVF or in-vitro fertilization is a hyped reproductive technology in which the ova from woman's ovaries and the sperm sample from a male is retrieved and manually diffused externally in a laboratory glass dish. After the fertilization these fertile eggs undergo embryo culture for a few days and transferred to the same or another woman's uterus in order to establish a successful pregnancy.
Key factors that are driving growth of the market are increasing incidence of infertility, rising number of fertility clinics and infertility services with government support and growing number of products launches and developments. However, the high procedural cost of reproductive techniques and risks associated with infertility treatment hinders the market growth. Moreover, the increasing trend of delayed pregnancy is contributing to the higher adoption of IVF techniques.
The cost of IVF service depends upon the IVF cycle performed, which nearly starts from US$ 15,000 or more. The cost may further increase along with the associated procedures such as ultrasounds, blood tests, lab work, and embryo storage among others.
The List of Companies - IVF Services Market
- Max Healthcare
- Bloom IVF
- CCRM Fertility.
- OXFORD FERTILITY
- Create Health (Create Fertility)
- Medicover
- Aevitas Fertility Clinic
- BIOART Fertility Clinic
- Prelude Fertility, Inc.
- Gift ov life
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)